Pigmentary Disorders


Introduction

Pigmentation refers to pigment formation in tissues. Abnormal accumulation or decreased / absent pigment causes skin pigmentation disorders that present as hyperchromic (hyperpigmentation) or hypochromic / achromic (leukoderma) lesions, respectively. The disorders may be caused by genetic, metabolic, endocrine, nutritional, neoplastic, chemical, physical, inflammatory, allergic, and infectious factors.

Hyperpigmentation

Hyperpigmentation may be endogenous or exogenous according to the origin of the pigment. It may also be congenital / hereditary or acquired.

Endogenous Hyperpigmentation

Melanin Hyperpigmentation

Melanin is a pigment produced by the melanocytes, within the melanosomes, in a reaction catalyzed by tyrosinase during the conversion of tyrosine into dopa. Melanin is transferred to the keratinocytes and phagocytosed by macrophages (melanophages) provided it reaches the dermis. There are two types of melanin: feomelanin, which is yellow to red, and eumelanin, which is brown to black. The latter is responsible for skin pigmentation and photoprotection.

Melanin is demonstrated by Fontana–Masson staining and dopa reaction.

Hereditary / Congenital Melanin Hyperpigmentation

Table 35-1 describes the congenital and / or hereditary focal melanocytic lesions.

TABLE 35-1
Hereditary  /  Congenital Focal Melanocytic and Leukoderma Lesions
Type Onset Clinical Aspects Most Frequent Sites Associations Pathologic Findings Malignization
Lentigo simplex Birth
Childhood Puberty
A regular brown or black macula less than 5 mm long, well defined borders, increases with age Any part of the body Peutz–Jeghers syndrome, Leopard syndrome, Carney Complex, LAMB syndrome, NAME syndrome Mild acanthosis, regular stretching of the epithelial crests, increased number of melanocytes, hyperpigmentation of the basal layer No
Ephelid Childhood
Puberty
Light or dark brown macula, 2–5 mm, poorly defined borders
Becomes darker during summer
Areas exposed to sunlight (face and shoulders) Normal epidermis, normal number of melanocytes, which are larger and more active No
Cafe-au-lait spot Birth
Childhood
Round or oval macula, larger than 5 mm, regular light brown pigmentation, well-defined borders Trunk or limbs Neurofibromatosis, Albright syndrome Increased melanin content in all layers of the epidermis No
Congenital melanocytic nevus Birth Small (less than 1.5 cm), medium (1.5–19.9 cm), giant (larger than 20 cm)
Dark brown to black plaque, well-defined borders, hypertrichosis, satellitosis
Lumbar region Neurocutaneous melanosis Individualized nevic cells among collagen fibers in the reticular dermis and subcutaneous tissue Yes (giant nevi)
Nevus spilus Birth
Childhood
Cafe-au-lait spot dotted with punctiform darker hyperpigmentation Trunk or limbs Macula: lentiginous epidermal hyperplasia, hyperpigmentation of the basal layer, increased number of melanocytes, punctiform elements: junctional or compound nevi Rare
Becker nevus Puberty Light or dark brown plaque, 10–20 cm, hair on the surface, rapid growth and then becomes stable. More frequent in men Shoulder, submammary or scapular regions Hypoplasia of ipsilateral breast, areola, nipple and arm Acanthosis, stretching of the epidermal crests, hyperpigmentation of the basal layer, normal or slightly increased number of melanocytes, increase in the number of hair follicles No
Nevus of Ota Birth
Childhood
Puberty
Blue-grayish macula, well-defined irregular borders Usually unilateral Eyes, eyelids and face; nasal, labial and palate mucosae Changes in the eye, neurocutanoeous melanoblastosis Normal epidermis
Intradermal dendritic melanocytic nevus
Rare
Nevus of Ito Birth
Childhood
Puberty
Blue-grayish macula, well-defined and irregular borders Scapular, supraclavicular, and deltoidean regions Normal epidermis
Intradermal dendritic melanocytic nevus
No
Common blue nevus Childhood Blue or black macula, isolated, less than 1 cm, well-defined regular borders Hands and feet Normal epidermis
Proliferation of dendritic melanocytes in the dermis
Rare
Cellular blue nevus Puberty
Adulthood (women)
Bluish papule, 1–3 cm, firm Buttocks and sacrococcigeal region Normal epidermis
Proliferation of dendritic melanocytes, spindle cells in the dermis
Rare
Ash-leaf spots Birth
Childhood
Hypochromic macula, 0.5–12 cm, resembling a leaf Trunk Tuberous sclerosis complex Normal number of melanocytes, but melanocyte activity is down regulated No
Achromic nevus ( Figure 35-3 ) Birth
Childhood
Puberty
Hypochromic macula, regular or irregular borders
It is permanent and does not increase in size
Usually unilateral, with metameric distribution Normal number of melanocytes, yet these are hypoactive No

Figure 35-1, Mongolian spot.

Mongolian Spot.

Mongolian spot is more frequently observed in black and Asian individuals. It is a circular or irregular blue-grayish spot, with poorly defined borders; it is localized on the buttocks and lumbosacral regions ( Fig. 35-1 ). It disappears by the age of 2 years. In other regions, areas of generalized, multiple, and deeper pigmentation may persist and be associated with some innate metabolism errors. Other malformations may also be present, including phakomathosis pigmentovascularis. Histologically, dendritic and spindle-shaped melanocytes are scattered deep in the dermis.

Incontinentia Pigmenti (Bloch–Sulzberger Syndrome).

This is a rare X-linked genodermatosis caused by a mutation in the NEMO gene. It affects female neonates and is usually lethal in males. The lesions follow the Blashko lines ( Fig. 35-2 ) and present in four developmental phases: vesicobullous, hyperkeratosis, hyperpigmentation, and hypopigmentation. Extracutaneous manifestations occur in 70–80% of cases. Histology findings depend on the developmental phase: vesicles containing eosinophils; hyperkeratosis, dyskeratosis, acanthosis and papillomatosis; pigmentary incontinence; or atrophy of the epidermis and annexes. Treatment is symptomatic.

Figure 35-2, Incontinentia pigmenti.

Figure 35-3, Achromic nevus.

Acquired Melanin Hyperpigmentation

Table 35-2 describes the acquired focal melanocytic changes.

TABLE 35-2
Acquired Focal Melanocytic Lesions
Type Onset Clinical Aspects Most Frequent Sites Associations Pathologic Findings Malignization
Common acquired melanocytic nevus Childhood
Puberty
Junctional: flat, homogeneous dark brown or black
Compound: light colored papule
Intradermal: light-colored papule
Increased number of nevi with age, fast growth during puberty, and maximum peak during the third decade of life
Any part of the body Nevus cells forming nests or cords
Junctional: dermal–epidermal junction
Intradermal: dermis
Compound: dermal–epidermal junction and dermis
Rare
Atypical nevus
(dysplastic)
Childhood
Puberty
Lesion 3–15 mm, macular surface in periphery and papule in central surface
Asymmetry, poorly defined and irregular borders, several colors
There may be erythema within or outside the lesion and hair
Trunk Atypical nevus syndrome Melanocytic hyperplasia and atypical melanocytes
Papillary dermis: eosinophilic fibrosis and perivascular lymphocyte infiltrate
Yes
Sutton nevus (halo nevus) Childhood
Puberty
Adulthood
Achromic halo surrounding a nevus that is usually undergoing regression Trunk Vitiligo Lymphocytic inflammatory reaction in a junctional, compound, intradermal, dysplastic nevus and melanoma Yes
Reed nevus (juvenile melanoma) Childhood
Puberty
Adulthood
(women)
Uniformly pigmented papule, 2–20 mm, defined regular borders Lower limbs Prevalence of spindle cells Rare
Spitz nevus Childhood
Puberty
Pink-brownish dome-shaped lesions, 2–20 mm, well-defined regular borders, smooth surface Face and neck Nests containing large and round melanocytes (epithelioid) and / or spindle shaped melanocytes
Vascular ectasia
Rare
Solar lentigo Adulthood > 30 years Light to dark brown spot, 5–15 mm, well-defined regular or irregular borders Areas exposed to sunlight, more specifically back of the hands, forearm and face Other actinic lesions Epidermal hyperplasia, regular stretching and anastomosis of interpapillary crests, normal or increased number of melanocytes, hyperpigmentation of the basal layer and solar elastosis No
Lentigo maligna Elderly Slow growing macula, various shades of brown, irregular borders Areas exposed to sunlight, especially the face Other actinic lesions Proliferation of atypical melanocytes within the atrophic epidermis and actinic degeneration Yes (lentigo maligna melanoma)
Seborrhoeic keratosis Adulthood Slightly raised and light brown lesions
Gradually they thicken and take on a rough, warty surface
Any part of the body Leser–Trelat syndrome Epidermal tumor composed of predominantly basaloid cells.
Hyperpigmentation of the basal layer
Acanthotic, hyperkeratotic, reticular or verrucous forms
No
Melanoma Adulthood
Rare in childhood and puberty
Flat, pigmented macules, papules or nodules. Rapid growth and metastasis Legs (women); Back (men); Palm, sole and subungual in Africans and Asians Proliferation of atypical melanocytes

Melasma (Chloasma).

This condition is frequently reported in dark-skinned women. Hormone, genetic, and racial factors are implied and sunlight exposure worsens the picture. Melasmas are brownish macules, with well-defined and irregular borders, located especially on the frontal, malar, and supralabial regions ( Fig. 35-4 ). Extrafacial manifestations may be present. According to the location of melanin, it may be epidermal (brown / black, intensified under Wood lamp), dermal (bluish), or dermal–epidermal. Treatment requires depigmenting substances: tyrosinase inhibitors (hydroquinone, arbutin, deoxyarbutin, aloesin, flavonoids, mequinol, rucinol, hydroxystilbene derivates, licorice extracts, kojic acid, azelaic acid, vitamin C, ellagic acid, gentisic acid, linoleic acid, dioic acid, cinnamic acid, silymarin), melanin transfer inhibitors (niacinamide, soymilk and soybean extracts, and lectins), or agents that accelerate skin scaling (retinoids, α-hydroxy acids, linoleic acid, salicylic acid, and mandelic acid). Hydroquinone 2–4% is the most efficacious agent. However, there are some concerns regarding its safety. Its efficacy may be increased by the association with tretinoin 0.025–0.1%. Corticosteroids reduce skin irritation. Photoprotection is essential. Topical antioxidants (vitamin C, vitamin E, tranexamic acid, and ferulic acid) help the skin-lightening process. Systemic antioxidants (β-carotene, vitamin C, vitamin E, Polypodium leucotomus extract, grapeseed extract, tranexamic acid, and pycnogenol) enhance the photoprotection. Peelings and laser therapy are used as coadjuvant treatment. The condition improves, but may recur.

Figure 35-4, Melasma.

Hyperpigmentation During Pregnancy.

A change in pigmentation is more intense in black skin and is associated with increased levels of melanocyte-stimulating hormone (MSH). Hyperpigmentation becomes more evident on the areolas, axillae, linea alba, genitals and medial aspect of the tights. Melasma is common. Pigmentation of scars and preexisting melanocytic lesions intensifies. Treatment is not necessary because the condition improves after the child is born.

Macular Amyloidosis.

This is a form of primary cutaneous amyloidosis, and its etiopathogenesis remains unclear. Epstein–Barr virus, genetic predisposition, atopy and friction are predisposing factors. It is more common in women between 21 and 50 years of age. The spots are brownish, lace-like, and usually located on the upper back. Histopathology reveals incontinentia pigmenti and amorphous material in the papillary dermis, which shows birefringence when stained by red Congo and under polarized light. Treatment is disappointing and the following may be used: topical corticoids, calcipotriol and dimethylsulfoxide, phototherapy, and Q-switched Nd : YAG laser.

Erythema Dyschromicum Perstans (Ashy Dermatosis).

This is an uncommon chronic disease, more common in young dark-skinned women, and it is not clear as yet whether it is a variant of lichen planus or a different entity. The predisposing factors include: pesticide use; contact with radiographic contrast medium; nematode, HIV, or hepatitis C virus infection; and immune, endocrine, or genetic disease. The blue-grayish, oval, or polycyclic maculae are asymptomatic, and present erythematous, initially elevated edges and centrifugal growth. Distribution is symmetric, with a preference for the face, neck, trunk, and proximal portions of the upper limbs. Histology shows vacuolation of the basal layer, colloid bodies, lymphocyte exocytosis, incontinentia pigmenti, and perivascular lymphocytic inflammatory infiltrate. Several treatments have been proposed including photoprotection, depigmentation, topical or systemic corticosteroids, isoniazid, griseofulvin, antimalarial, dapsone, clofazimine, phototherapy, and laser therapy.

Postinflammatory Hyperpigmentation.

This condition is more common in black individuals and occurs after some skin conditions (e.g., lichen planus, acne, drug reactions, phototoxic and photoallergic reactions, mastocytosis, prurigo) or injuries (e.g., trauma, peelings, chronic friction). It is more associated with the nature of the aggression than with the grade of inflammation. Maculae are present in the previous inflammatory sites, and their intensity is directly associated with the phototype ( Figs. 35-5 and 35-6 ). The site of the melanin determines the color: brown (epidermis) or blue-grayish (dermis). Sunlight exposure or persistent inflammation worsens the condition. Histopathology shows increased melanin content in the basal layer, incontinentia pigmenti, and superficial perivascular lymphocytic and hystiocytic infiltrate. The treatment consists of eradicating the underlying skin condition with corticosteroids, tacrolimus, pimecrolimus, or topic depigmentation agents; however, attention should be given to worsening of the picture if irritation occurs. It persists for months and regression is slow in epidermal pigmentation, or remains in the dermis.

Figure 35-5, Postinflammatory hyperpigmentation.

Figure 35-6, Postinflammatory hyperpigmentation: phototoxic reaction.

Acanthosis Nigricans.

Dark velvet-like spots are observed on the neck, axillae, groins, and periumbilical and inframammary regions ( Fig. 35-7 ). They may indicate an internal disease, and be associated with obesity, diabetes mellitus, polycystic ovary syndrome, Cushing syndrome, or malignancy, especially gastric adenocarcinoma, or with certain medications. Histology reveals hyperkeratosis, hyperpigmentation, and papillomatosis. Improvement is related to resolution of the underlying disease. Treatment may include keratolytic agents, urea, hydroquinone, and retinoic acid. Systemic treatment includes isotretinoin and metformin (hyperandrogenism) and the procedures used are peeling and laser therapy.

Figure 35-7, Acanthosis nigricans.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here